Hepcidin After Intravenous Iron Treatment
The aim of this study is to investigate the hepcidin hormone response after intravenous iron administration.
- EligibilityCriteria: Inclusion Criteria:  informed consent as documented by signature iron-deficiency (serum ferritin <30ng/ml) female gender premenopausal age >18 years body mass index (BMI) in normal range (18-25 kg/m²) the participant is linguistically and cognitively able to understand the study procedure  Exclusion Criteria:  anaemia (hemoglobin <117g/l) allergy or contraindications for iron infusions anamnestic current pregnancy breastfeeding chronic inflammatory diseases (e.g. colitis) liver disease (alanine transaminase (ALT) >35 U/l) increased C-reactive protein (CRP) (>5mg/l) intake of dietary supplements containing iron (last 7 days) - HealthyVolunteers: No - Gender: Female - GenderBased: Yes - MinimumAge: 18 Years - MaximumAge: 50 Years - StdAgeList: Adult - StudyPopulation: iron deficient non-anemic women - SamplingMethod: Non-Probability Sample